Vertex Pharmaceuticals, Inc. (VRTX)
522.38
+6.04
(+1.17%)
USD |
NASDAQ |
Sep 24, 16:00
522.89
+0.51
(+0.10%)
After-Hours: 19:59
Vertex Pharmaceuticals Gross Profit (Annual) : 10.27B for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 10.27B |
| December 31, 2024 | 9.454B |
| December 31, 2023 | 8.577B |
| December 31, 2022 | 7.668B |
| December 31, 2021 | 6.700B |
| December 31, 2020 | 5.473B |
| December 31, 2019 | 3.583B |
| December 31, 2018 | 2.639B |
| December 31, 2017 | 2.214B |
| December 31, 2016 | 1.492B |
| December 31, 2015 | 907.82M |
| December 31, 2014 | 487.80M |
| December 31, 2013 | 1.082B |
| December 31, 2012 | 1.247B |
| December 31, 2011 | 1.330B |
| December 31, 2010 | 100.18M |
| December 31, 2009 | 57.58M |
| December 31, 2008 | 127.62M |
| Date | Value |
|---|---|
| December 31, 2007 | 157.65M |
| December 31, 2006 | 178.32M |
| December 31, 2005 | 123.50M |
| December 31, 2004 | 67.43M |
| December 31, 2003 | 42.58M |
| December 31, 2002 | 132.80M |
| December 31, 2001 | 127.86M |
| December 31, 2000 | 64.95M |
| December 31, 1999 | 41.43M |
| December 31, 1998 | 0.00 |
| December 31, 1997 | 26.34M |
| December 31, 1996 | 0.00 |
| December 31, 1995 | 0.00 |
| December 31, 1994 | 0.00 |
| December 31, 1993 | 0.00 |
| December 31, 1992 | 0.00 |
| December 31, 1991 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Gilead Sciences, Inc. | 23.22B |
| Alnylam Pharmaceuticals, Inc. | 3.032B |
| Sionna Therapeutics, Inc. | -0.647M |
| Regeneron Pharmaceuticals, Inc. | 11.70B |
| Amgen, Inc. | 26.01B |